ARCHIVES

Rewritten Five Year Plan For Centers Is Greeted Warmly By NCAB Committee

This article is from The Cancer Letter archive.

Vol. 16 No. 17 | April 27, 1990

Download PDF Visit The Full Archive

Related Articles

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

Senate Gives NIH Director Authority To Permit Research By Unconventional MDs

September 25, 1992

Penn Begins Clinical Trial Of A Vaccine For Breast Cancer Based On Telomerase

February 27, 2004

Panel Waffles On One Vs. Three Year Intervals For Pap Test, Agrees On when They Should Start

August 1, 1980